nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Infestation—Capecitabine—prostate cancer	0.0013	0.0013	CcSEcCtD
Ceftaroline fosamil—Vomiting—Ethinyl Estradiol—prostate cancer	0.0013	0.0013	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Estradiol—prostate cancer	0.00129	0.00129	CcSEcCtD
Ceftaroline fosamil—Rash—Ethinyl Estradiol—prostate cancer	0.00129	0.00129	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00129	0.00129	CcSEcCtD
Ceftaroline fosamil—Renal failure—Capecitabine—prostate cancer	0.00128	0.00128	CcSEcCtD
Ceftaroline fosamil—Headache—Ethinyl Estradiol—prostate cancer	0.00128	0.00128	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Docetaxel—prostate cancer	0.00127	0.00127	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Doxorubicin—prostate cancer	0.00126	0.00126	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Mitoxantrone—prostate cancer	0.00124	0.00124	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Goserelin—prostate cancer	0.00124	0.00124	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Capecitabine—prostate cancer	0.00123	0.00123	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.00123	0.00123	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Prednisone—prostate cancer	0.00122	0.00122	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Mitoxantrone—prostate cancer	0.00121	0.00121	CcSEcCtD
Ceftaroline fosamil—Nausea—Ethinyl Estradiol—prostate cancer	0.00121	0.00121	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Docetaxel—prostate cancer	0.00121	0.00121	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Mitoxantrone—prostate cancer	0.0012	0.0012	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Docetaxel—prostate cancer	0.00119	0.00119	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Capecitabine—prostate cancer	0.00119	0.00119	CcSEcCtD
Ceftaroline fosamil—Pruritus—Goserelin—prostate cancer	0.00119	0.00119	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Docetaxel—prostate cancer	0.00118	0.00118	CcSEcCtD
Ceftaroline fosamil—Pruritus—Conjugated Estrogens—prostate cancer	0.00118	0.00118	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Prednisone—prostate cancer	0.00117	0.00117	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Capecitabine—prostate cancer	0.00117	0.00117	CcSEcCtD
Ceftaroline fosamil—Anaemia—Etoposide—prostate cancer	0.00117	0.00117	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Capecitabine—prostate cancer	0.00115	0.00115	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Estradiol—prostate cancer	0.00115	0.00115	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Goserelin—prostate cancer	0.00115	0.00115	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Capecitabine—prostate cancer	0.00115	0.00115	CcSEcCtD
Ceftaroline fosamil—Constipation—Estradiol—prostate cancer	0.00114	0.00114	CcSEcCtD
Ceftaroline fosamil—Pain—Estradiol—prostate cancer	0.00114	0.00114	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Conjugated Estrogens—prostate cancer	0.00114	0.00114	CcSEcCtD
Ceftaroline fosamil—Dizziness—Goserelin—prostate cancer	0.00111	0.00111	CcSEcCtD
Ceftaroline fosamil—Dizziness—Conjugated Estrogens—prostate cancer	0.0011	0.0011	CcSEcCtD
Ceftaroline fosamil—Convulsion—Etoposide—prostate cancer	0.0011	0.0011	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Docetaxel—prostate cancer	0.00109	0.00109	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Docetaxel—prostate cancer	0.00109	0.00109	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Estradiol—prostate cancer	0.00109	0.00109	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Epirubicin—prostate cancer	0.00107	0.00107	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.00107	0.00107	CcSEcCtD
Ceftaroline fosamil—Vomiting—Goserelin—prostate cancer	0.00107	0.00107	CcSEcCtD
Ceftaroline fosamil—Constipation—Mitoxantrone—prostate cancer	0.00106	0.00106	CcSEcCtD
Ceftaroline fosamil—Pain—Mitoxantrone—prostate cancer	0.00106	0.00106	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Capecitabine—prostate cancer	0.00106	0.00106	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Prednisone—prostate cancer	0.00106	0.00106	CcSEcCtD
Ceftaroline fosamil—Rash—Goserelin—prostate cancer	0.00106	0.00106	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Goserelin—prostate cancer	0.00106	0.00106	CcSEcCtD
Ceftaroline fosamil—Vomiting—Conjugated Estrogens—prostate cancer	0.00106	0.00106	CcSEcCtD
Ceftaroline fosamil—Urticaria—Estradiol—prostate cancer	0.00106	0.00106	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Capecitabine—prostate cancer	0.00106	0.00106	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Estradiol—prostate cancer	0.00105	0.00105	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Estradiol—prostate cancer	0.00105	0.00105	CcSEcCtD
Ceftaroline fosamil—Headache—Goserelin—prostate cancer	0.00105	0.00105	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Docetaxel—prostate cancer	0.00105	0.00105	CcSEcCtD
Ceftaroline fosamil—Erythema—Docetaxel—prostate cancer	0.00105	0.00105	CcSEcCtD
Ceftaroline fosamil—Rash—Conjugated Estrogens—prostate cancer	0.00105	0.00105	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Conjugated Estrogens—prostate cancer	0.00105	0.00105	CcSEcCtD
Ceftaroline fosamil—Headache—Conjugated Estrogens—prostate cancer	0.00104	0.00104	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Etoposide—prostate cancer	0.00103	0.00103	CcSEcCtD
Ceftaroline fosamil—Erythema—Capecitabine—prostate cancer	0.00102	0.00102	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Capecitabine—prostate cancer	0.00102	0.00102	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.00101	0.00101	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Etoposide—prostate cancer	0.00101	0.00101	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Epirubicin—prostate cancer	0.00101	0.00101	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Etoposide—prostate cancer	0.001	0.001	CcSEcCtD
Ceftaroline fosamil—Nausea—Goserelin—prostate cancer	0.000997	0.000997	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Doxorubicin—prostate cancer	0.000991	0.000991	CcSEcCtD
Ceftaroline fosamil—Nausea—Conjugated Estrogens—prostate cancer	0.000988	0.000988	CcSEcCtD
Ceftaroline fosamil—Urticaria—Mitoxantrone—prostate cancer	0.000985	0.000985	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Estradiol—prostate cancer	0.000981	0.000981	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Mitoxantrone—prostate cancer	0.00098	0.00098	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Mitoxantrone—prostate cancer	0.00098	0.00098	CcSEcCtD
Ceftaroline fosamil—Anaemia—Docetaxel—prostate cancer	0.000971	0.000971	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Epirubicin—prostate cancer	0.000951	0.000951	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Prednisone—prostate cancer	0.000944	0.000944	CcSEcCtD
Ceftaroline fosamil—Pruritus—Estradiol—prostate cancer	0.000942	0.000942	CcSEcCtD
Ceftaroline fosamil—Anaemia—Capecitabine—prostate cancer	0.00094	0.00094	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Prednisone—prostate cancer	0.00094	0.00094	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Doxorubicin—prostate cancer	0.000932	0.000932	CcSEcCtD
Ceftaroline fosamil—Palpitations—Docetaxel—prostate cancer	0.000928	0.000928	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Epirubicin—prostate cancer	0.000917	0.000917	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Mitoxantrone—prostate cancer	0.000914	0.000914	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Estradiol—prostate cancer	0.000911	0.000911	CcSEcCtD
Ceftaroline fosamil—Convulsion—Docetaxel—prostate cancer	0.00091	0.00091	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Epirubicin—prostate cancer	0.000907	0.000907	CcSEcCtD
Ceftaroline fosamil—Infestation—Epirubicin—prostate cancer	0.000907	0.000907	CcSEcCtD
Ceftaroline fosamil—Erythema—Prednisone—prostate cancer	0.000906	0.000906	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Prednisone—prostate cancer	0.000906	0.000906	CcSEcCtD
Ceftaroline fosamil—Palpitations—Capecitabine—prostate cancer	0.000899	0.000899	CcSEcCtD
Ceftaroline fosamil—Renal failure—Epirubicin—prostate cancer	0.000891	0.000891	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Etoposide—prostate cancer	0.000891	0.000891	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000888	0.000888	CcSEcCtD
Ceftaroline fosamil—Constipation—Etoposide—prostate cancer	0.000882	0.000882	CcSEcCtD
Ceftaroline fosamil—Pain—Etoposide—prostate cancer	0.000882	0.000882	CcSEcCtD
Ceftaroline fosamil—Dizziness—Estradiol—prostate cancer	0.00088	0.00088	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Doxorubicin—prostate cancer	0.00088	0.00088	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.00086	0.00086	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Epirubicin—prostate cancer	0.000857	0.000857	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Docetaxel—prostate cancer	0.000857	0.000857	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Doxorubicin—prostate cancer	0.000849	0.000849	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Mitoxantrone—prostate cancer	0.000849	0.000849	CcSEcCtD
Ceftaroline fosamil—Vomiting—Estradiol—prostate cancer	0.000846	0.000846	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Etoposide—prostate cancer	0.000844	0.000844	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Docetaxel—prostate cancer	0.000841	0.000841	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Docetaxel—prostate cancer	0.000839	0.000839	CcSEcCtD
Ceftaroline fosamil—Rash—Estradiol—prostate cancer	0.000839	0.000839	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Doxorubicin—prostate cancer	0.000839	0.000839	CcSEcCtD
Ceftaroline fosamil—Infestation—Doxorubicin—prostate cancer	0.000839	0.000839	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Estradiol—prostate cancer	0.000838	0.000838	CcSEcCtD
Ceftaroline fosamil—Anaemia—Prednisone—prostate cancer	0.000837	0.000837	CcSEcCtD
Ceftaroline fosamil—Headache—Estradiol—prostate cancer	0.000834	0.000834	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Docetaxel—prostate cancer	0.000833	0.000833	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Epirubicin—prostate cancer	0.000829	0.000829	CcSEcCtD
Ceftaroline fosamil—Renal failure—Doxorubicin—prostate cancer	0.000825	0.000825	CcSEcCtD
Ceftaroline fosamil—Urticaria—Etoposide—prostate cancer	0.00082	0.00082	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Etoposide—prostate cancer	0.000815	0.000815	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Etoposide—prostate cancer	0.000815	0.000815	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Capecitabine—prostate cancer	0.000814	0.000814	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Epirubicin—prostate cancer	0.000814	0.000814	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Capecitabine—prostate cancer	0.000813	0.000813	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Capecitabine—prostate cancer	0.000806	0.000806	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Epirubicin—prostate cancer	0.000804	0.000804	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Epirubicin—prostate cancer	0.000798	0.000798	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000793	0.000793	CcSEcCtD
Ceftaroline fosamil—Nausea—Estradiol—prostate cancer	0.000791	0.000791	CcSEcCtD
Ceftaroline fosamil—Vomiting—Mitoxantrone—prostate cancer	0.000789	0.000789	CcSEcCtD
Ceftaroline fosamil—Convulsion—Prednisone—prostate cancer	0.000785	0.000785	CcSEcCtD
Ceftaroline fosamil—Rash—Mitoxantrone—prostate cancer	0.000782	0.000782	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Mitoxantrone—prostate cancer	0.000781	0.000781	CcSEcCtD
Ceftaroline fosamil—Headache—Mitoxantrone—prostate cancer	0.000777	0.000777	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Doxorubicin—prostate cancer	0.000767	0.000767	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000766	0.000766	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Etoposide—prostate cancer	0.00076	0.00076	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Doxorubicin—prostate cancer	0.000753	0.000753	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Doxorubicin—prostate cancer	0.000744	0.000744	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Docetaxel—prostate cancer	0.00074	0.00074	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Prednisone—prostate cancer	0.000739	0.000739	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Epirubicin—prostate cancer	0.000738	0.000738	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Doxorubicin—prostate cancer	0.000738	0.000738	CcSEcCtD
Ceftaroline fosamil—Nausea—Mitoxantrone—prostate cancer	0.000737	0.000737	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Epirubicin—prostate cancer	0.000735	0.000735	CcSEcCtD
Ceftaroline fosamil—Pain—Docetaxel—prostate cancer	0.000733	0.000733	CcSEcCtD
Ceftaroline fosamil—Constipation—Docetaxel—prostate cancer	0.000733	0.000733	CcSEcCtD
Ceftaroline fosamil—Pruritus—Etoposide—prostate cancer	0.00073	0.00073	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Prednisone—prostate cancer	0.000725	0.000725	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Prednisone—prostate cancer	0.000718	0.000718	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000717	0.000717	CcSEcCtD
Ceftaroline fosamil—Pain—Capecitabine—prostate cancer	0.00071	0.00071	CcSEcCtD
Ceftaroline fosamil—Constipation—Capecitabine—prostate cancer	0.00071	0.00071	CcSEcCtD
Ceftaroline fosamil—Erythema—Epirubicin—prostate cancer	0.000709	0.000709	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Epirubicin—prostate cancer	0.000709	0.000709	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Etoposide—prostate cancer	0.000706	0.000706	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Docetaxel—prostate cancer	0.000701	0.000701	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Doxorubicin—prostate cancer	0.000683	0.000683	CcSEcCtD
Ceftaroline fosamil—Dizziness—Etoposide—prostate cancer	0.000682	0.000682	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Doxorubicin—prostate cancer	0.00068	0.00068	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Capecitabine—prostate cancer	0.000679	0.000679	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Docetaxel—prostate cancer	0.000678	0.000678	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Docetaxel—prostate cancer	0.000678	0.000678	CcSEcCtD
Ceftaroline fosamil—Urticaria—Capecitabine—prostate cancer	0.000659	0.000659	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Capecitabine—prostate cancer	0.000656	0.000656	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Capecitabine—prostate cancer	0.000656	0.000656	CcSEcCtD
Ceftaroline fosamil—Vomiting—Etoposide—prostate cancer	0.000656	0.000656	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Doxorubicin—prostate cancer	0.000656	0.000656	CcSEcCtD
Ceftaroline fosamil—Erythema—Doxorubicin—prostate cancer	0.000656	0.000656	CcSEcCtD
Ceftaroline fosamil—Anaemia—Epirubicin—prostate cancer	0.000655	0.000655	CcSEcCtD
Ceftaroline fosamil—Rash—Etoposide—prostate cancer	0.00065	0.00065	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Etoposide—prostate cancer	0.00065	0.00065	CcSEcCtD
Ceftaroline fosamil—Headache—Etoposide—prostate cancer	0.000646	0.000646	CcSEcCtD
Ceftaroline fosamil—Constipation—Prednisone—prostate cancer	0.000632	0.000632	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Docetaxel—prostate cancer	0.000632	0.000632	CcSEcCtD
Ceftaroline fosamil—Palpitations—Epirubicin—prostate cancer	0.000626	0.000626	CcSEcCtD
Ceftaroline fosamil—Convulsion—Epirubicin—prostate cancer	0.000614	0.000614	CcSEcCtD
Ceftaroline fosamil—Nausea—Etoposide—prostate cancer	0.000613	0.000613	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Capecitabine—prostate cancer	0.000612	0.000612	CcSEcCtD
Ceftaroline fosamil—Pruritus—Docetaxel—prostate cancer	0.000607	0.000607	CcSEcCtD
Ceftaroline fosamil—Anaemia—Doxorubicin—prostate cancer	0.000606	0.000606	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Prednisone—prostate cancer	0.000605	0.000605	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000599	0.000599	CcSEcCtD
Ceftaroline fosamil—Urticaria—Prednisone—prostate cancer	0.000587	0.000587	CcSEcCtD
Ceftaroline fosamil—Pruritus—Capecitabine—prostate cancer	0.000587	0.000587	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Docetaxel—prostate cancer	0.000587	0.000587	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Prednisone—prostate cancer	0.000584	0.000584	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Prednisone—prostate cancer	0.000584	0.000584	CcSEcCtD
Ceftaroline fosamil—Palpitations—Doxorubicin—prostate cancer	0.000579	0.000579	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Epirubicin—prostate cancer	0.000578	0.000578	CcSEcCtD
Ceftaroline fosamil—Convulsion—Doxorubicin—prostate cancer	0.000568	0.000568	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Capecitabine—prostate cancer	0.000568	0.000568	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Epirubicin—prostate cancer	0.000567	0.000567	CcSEcCtD
Ceftaroline fosamil—Dizziness—Docetaxel—prostate cancer	0.000567	0.000567	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Epirubicin—prostate cancer	0.000566	0.000566	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Epirubicin—prostate cancer	0.000562	0.000562	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000554	0.000554	CcSEcCtD
Ceftaroline fosamil—Dizziness—Capecitabine—prostate cancer	0.000549	0.000549	CcSEcCtD
Ceftaroline fosamil—Vomiting—Docetaxel—prostate cancer	0.000545	0.000545	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Prednisone—prostate cancer	0.000545	0.000545	CcSEcCtD
Ceftaroline fosamil—Rash—Docetaxel—prostate cancer	0.000541	0.000541	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Docetaxel—prostate cancer	0.00054	0.00054	CcSEcCtD
Ceftaroline fosamil—Headache—Docetaxel—prostate cancer	0.000537	0.000537	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Doxorubicin—prostate cancer	0.000535	0.000535	CcSEcCtD
Ceftaroline fosamil—Vomiting—Capecitabine—prostate cancer	0.000528	0.000528	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Doxorubicin—prostate cancer	0.000525	0.000525	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Doxorubicin—prostate cancer	0.000524	0.000524	CcSEcCtD
Ceftaroline fosamil—Rash—Capecitabine—prostate cancer	0.000523	0.000523	CcSEcCtD
Ceftaroline fosamil—Pruritus—Prednisone—prostate cancer	0.000523	0.000523	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Capecitabine—prostate cancer	0.000523	0.000523	CcSEcCtD
Ceftaroline fosamil—Headache—Capecitabine—prostate cancer	0.00052	0.00052	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Doxorubicin—prostate cancer	0.00052	0.00052	CcSEcCtD
Ceftaroline fosamil—Nausea—Docetaxel—prostate cancer	0.000509	0.000509	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Prednisone—prostate cancer	0.000506	0.000506	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000499	0.000499	CcSEcCtD
Ceftaroline fosamil—Constipation—Epirubicin—prostate cancer	0.000494	0.000494	CcSEcCtD
Ceftaroline fosamil—Pain—Epirubicin—prostate cancer	0.000494	0.000494	CcSEcCtD
Ceftaroline fosamil—Nausea—Capecitabine—prostate cancer	0.000493	0.000493	CcSEcCtD
Ceftaroline fosamil—Dizziness—Prednisone—prostate cancer	0.000489	0.000489	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Epirubicin—prostate cancer	0.000473	0.000473	CcSEcCtD
Ceftaroline fosamil—Vomiting—Prednisone—prostate cancer	0.00047	0.00047	CcSEcCtD
Ceftaroline fosamil—Rash—Prednisone—prostate cancer	0.000466	0.000466	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Prednisone—prostate cancer	0.000466	0.000466	CcSEcCtD
Ceftaroline fosamil—Headache—Prednisone—prostate cancer	0.000463	0.000463	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000462	0.000462	CcSEcCtD
Ceftaroline fosamil—Urticaria—Epirubicin—prostate cancer	0.000459	0.000459	CcSEcCtD
Ceftaroline fosamil—Pain—Doxorubicin—prostate cancer	0.000458	0.000458	CcSEcCtD
Ceftaroline fosamil—Constipation—Doxorubicin—prostate cancer	0.000458	0.000458	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Epirubicin—prostate cancer	0.000457	0.000457	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Epirubicin—prostate cancer	0.000457	0.000457	CcSEcCtD
Ceftaroline fosamil—Nausea—Prednisone—prostate cancer	0.000439	0.000439	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000438	0.000438	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Epirubicin—prostate cancer	0.000426	0.000426	CcSEcCtD
Ceftaroline fosamil—Urticaria—Doxorubicin—prostate cancer	0.000425	0.000425	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Doxorubicin—prostate cancer	0.000423	0.000423	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Doxorubicin—prostate cancer	0.000423	0.000423	CcSEcCtD
Ceftaroline fosamil—Pruritus—Epirubicin—prostate cancer	0.000409	0.000409	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Epirubicin—prostate cancer	0.000396	0.000396	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Doxorubicin—prostate cancer	0.000394	0.000394	CcSEcCtD
Ceftaroline fosamil—Dizziness—Epirubicin—prostate cancer	0.000382	0.000382	CcSEcCtD
Ceftaroline fosamil—Pruritus—Doxorubicin—prostate cancer	0.000379	0.000379	CcSEcCtD
Ceftaroline fosamil—Vomiting—Epirubicin—prostate cancer	0.000368	0.000368	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Doxorubicin—prostate cancer	0.000366	0.000366	CcSEcCtD
Ceftaroline fosamil—Rash—Epirubicin—prostate cancer	0.000365	0.000365	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Epirubicin—prostate cancer	0.000364	0.000364	CcSEcCtD
Ceftaroline fosamil—Headache—Epirubicin—prostate cancer	0.000362	0.000362	CcSEcCtD
Ceftaroline fosamil—Dizziness—Doxorubicin—prostate cancer	0.000354	0.000354	CcSEcCtD
Ceftaroline fosamil—Nausea—Epirubicin—prostate cancer	0.000343	0.000343	CcSEcCtD
Ceftaroline fosamil—Vomiting—Doxorubicin—prostate cancer	0.00034	0.00034	CcSEcCtD
Ceftaroline fosamil—Rash—Doxorubicin—prostate cancer	0.000337	0.000337	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Doxorubicin—prostate cancer	0.000337	0.000337	CcSEcCtD
Ceftaroline fosamil—Headache—Doxorubicin—prostate cancer	0.000335	0.000335	CcSEcCtD
Ceftaroline fosamil—Nausea—Doxorubicin—prostate cancer	0.000318	0.000318	CcSEcCtD
